Clinical reference Biomarker Directory
Back to directory

N-terminal pro-B-type Natriuretic peptide

Established

NT-proBNP is BNP's longer-lasting precursor fragment, often preferred for heart failure diagnosis due to its stability.

Also known as NT-proBNP
In plain language

NT-proBNP is a close relative of BNP, made from the same starting molecule, but it lasts longer in the blood, which is why many labs prefer measuring it. The same age and weight-related interpretation caveats that apply to BNP apply here too.

Biomarker & context

NT-proBNP is the inactive fragment cleaved from proBNP when the heart releases active BNP under wall-stress conditions; because of its longer half-life, it is often preferred over BNP itself in clinical labs for diagnosing and staging heart failure.

What it indicates

Elevated NT-proBNP supports a heart failure diagnosis and correlates with severity, following the same overall diagnostic framework as BNP, since both markers originate from the same precursor molecule and reflect the same underlying cardiac stress.

Diagnosis & clinical testing

Guideline cutoffs vary by clinical setting: NICE recommends >400 ng/L and ESC recommends >125 ng/L for outpatient workup; because NT-proBNP's longer half-life (120 minutes vs. BNP's 20 minutes) produces more stable, typically higher absolute values, its reference ranges and cutoffs are distinct from BNP's and the two are not interchangeable.

Guiding treatment

As with BNP, current research argues for age-adjusted thresholds and recognizes that levels run lower in patients with obesity, which can mask heart failure under a universal cutoff — the same clinical caveats apply to NT-proBNP as to BNP.

Clinical significance

Not directly interchangeable with BNP values; each has distinct reference ranges and guideline cutoffs.

References
  1. Medscape. Brain-Type Natriuretic Peptide (BNP) and NT-proBNP: Reference Range, Interpretation, Collection and Panels.